Nanoparticles in radiation therapy: A summary of various approaches to enhance radiosensitization in cancer

Translational Cancer Research

Volumn 2, Issue 4, 2013, Pages 330-342

  Kwatra, Deep ^a   Venugopal, Anand ^a   Anant, Shrikant ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS CANCER CENTER   (United States)

Author keywords

High Z metal nanoparticles; Radiation resistance; Radio protection

Indexed keywords

EID: 84962741532     PISSN: 2218676X     EISSN: 22196803     Source Type: Journal    
DOI: 10.3978/j.issn.2218-676X.2013.08.06     Document Type: Article

References (112)

1. Hogle WP. The state of the art in radiation therapy. Semin Oncol Nurs 2006;22:212-20.
2. Mallick I, Waldron JN. Radiation therapy for head and neck cancers. Semin Oncol Nurs 2009;25:193-202.
3. Halliwell B, Aruoma OI. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett 1991;281:9-19.
4. Herold DM, Das IJ, Stobbe CC, et al. Gold microspheres: a selective technique for producing biologically effective dose enhancement. Int J Radiat Biol 2000;76:1357-64.
5. Park YS, Liz-Marzán LM, Kasuya A, et al. X-ray absorption of gold nanoparticles with thin silica shell. J Nanosci Nanotechnol 2006;6:3503-6.
6. Carter JD, Cheng NN, Qu Y, et al. Nanoscale energy deposition by X-ray absorbing nanostructures. J Phys Chem B 2007;111:11622-5.
7. Praetorius NP, Mandal TK. Engineered nanoparticles in cancer therapy. Recent Pat Drug Deliv Formul 2007;1:37-51.
8. Adams FH, Norman A, Mello RS, et al. Effect of radiation and contrast media on chromosomes. Preliminary report. Radiology 1977;124:823-6.
9. Matsudaira H, Ueno AM, Furuno I. Iodine contrast medium sensitizes cultured mammalian cells to X rays but not to gamma rays. Radiat Res 1980;84:144-8.
10. Jeremic B, Aguerri AR, Filipovic N. Radiosensitization by gold nanoparticles. Clin Transl Oncol 2013;15:593-601.
11. Larson TA, Joshi PP, Sokolov K. Preventing protein adsorption and macrophage uptake of gold nanoparticles via a hydrophobic shield. ACS Nano 2012;6:9182-90.
12. Wang M, Thanou M. Targeting nanoparticles to cancer. Pharmacol Res 2010;62:90-9.
13. Zheng Y, Hunting DJ, Ayotte P, et al. Radiosensitization of DNA by gold nanoparticles irradiated with high-energy electrons. Radiat Res 2008;169:19-27.
14. Brun E, Sanche L, Sicard-Roselli C. Parameters governing gold nanoparticle X-ray radiosensitization of DNA in solution. Colloids Surf B Biointerfaces 2009;72:128-34.
15. Lechtman E, Chattopadhyay N, Cai Z, et al. Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location. Phys Med Biol 2011;56:4631-47.
16. McMahon SJ, Prise KM, Currell FJ. Comment on 'implications on clinical scenario of gold nanoparticle radiosensitization in regard to photon energy, nanoparticle size, concentration and location'. Phys Med Biol 2012;57:287-90; discussion 291-5.
17. Ngwa W, Korideck H, Kassis AI, et al. In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. Nanomedicine 2013;9:25-7.
18. Alqathami M, Blencowe A, Yeo UJ, et al. Novel multicompartment 3-dimensional radiochromic radiation dosimeters for nanoparticle-enhanced radiation therapy dosimetry. Int J Radiat Oncol Biol Phys 2012;84:e549-55.
19. Joh DY, Sun L, Stangl M, et al. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLoS One 2013;8:e62425.
20. Bobyk L, Edouard M, Deman P, et al. Photoactivation of gold nanoparticles for glioma treatment. Nanomedicine 2013. [Epub ahead of print].
21. Xiao F, Zheng Y, Cloutier P, et al. On the role of low-energy electrons in the radiosensitization of DNA by gold nanoparticles. Nanotechnology 2011;22:465101.
22. Liu CJ, Wang CH, Chien CC, et al. Enhanced x-ray irradiation-induced cancer cell damage by gold nanoparticles treated by a new synthesis method of polyethylene glycol modification. Nanotechnology 2008;19:295104.
23. Liu CJ, Wang CH, Chen ST, et al. Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Phys Med Biol 2010;55:931-45.
24. Zhang XD, Wu D, Shen X, et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 2012;33:6408-19.
25. Cho WS, Kim S, Han BS, et al. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. Toxicol Lett 2009;191:96-102.
26. Zhang XD, Wu D, Shen X, et al. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomedicine 2011;6:2071-81.
27. Coulter JA, Jain S, Butterworth KT, et al. Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles. Int J Nanomedicine 2012;7:2673-85.
28. Zhang XD, Wu HY, Wu D, et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int J Nanomedicine 2010;5:771-81.
29. Jeong SY, Park SJ, Yoon SM, et al. Systemic delivery and preclinical evaluation of Au nanoparticle containing beta-lapachone for radiosensitization. J Control Release 2009;139:239-45.
30. Riva P, Franceschi G, Riva N, et al. Role of nuclear medicine in the treatment of malignant gliomas: the locoregional radioimmunotherapy approach. Eur J Nucl Med 2000;27:601-9.
31. Chattopadhyay N, Cai Z, Kwon YL, et al. Molecularly targeted gold nanoparticles enhance the radiation response of breast cancer cells and tumor xenografts to X-radiation. Breast Cancer Res Treat 2013;137:81-91.
32. Zheng Y, Hunting DJ, Ayotte P, et al. Role of secondary low-energy electrons in the concomitant chemoradiation therapy of cancer. Phys Rev Lett 2008;100:198101.
33. Zheng Y, Sanche L. Gold nanoparticles enhance DNA damage induced by anti-cancer drugs and radiation. Radiat Res 2009;172:114-9.
34. Young SW, Qing F, Harriman A, et al. Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI. Proc Natl Acad Sci U S A 1996;93:6610-5.
35. Bernhard EJ, Mitchell JB, Deen D, et al. Re-evaluating gadolinium(III) texaphyrin as a radiosensitizing agent. Cancer Res 2000;60:86-91.
36. Tokumitsu H, Hiratsuka J, Sakurai Y, et al. Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor. Cancer Lett 2000;150:177-82.
37. Mowat P, Mignot A, Rima W, et al. In vitro radiosensitizing effects of ultrasmall gadolinium based particles on tumour cells. J Nanosci Nanotechnol 2011;11:7833-9.
38. Rima W, Sancey L, Aloy MT, et al. Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles. Biomaterials 2013;34:181-95.
39. Sotter E, Vilanova X, Llobet E, et al. Niobium-doped titania nanopowders for gas sensor applications. J Optoelectron Adv Mater 2005;7:1395-8.
40. Townley HE, Kim J, Dobson PJ. In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles. Nanoscale 2012;4:5043-50.
41. Gratton SE, Ropp PA, Pohlhaus PD, et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A 2008;105:11613-8.
42. Mirjolet C, Papa AL, Créhange G, et al. The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: A proof-of-concept. Radiother Oncol 2013;108:136-42.
43. Blatnik J, Luebke L, Simonet S, et al. Dye surface coating enables visible light activation of TiO2 nanoparticles leading to degradation of neighboring biological structures. Microsc Microanal 2012;18:134-42.
44. Hong C, An S, Son M, et al. In-vitro cell tests using doxorubicin-loaded polymeric TiO2 nanotubes used for cancer photothermotherapy. Anticancer Drugs 2012;23:553-60.
45. Petković J, Küzma T, Rade K, et al. Pre-irradiation of anatase TiO2 particles with UV enhances their cytotoxic and genotoxic potential in human hepatoma HepG2 cells. J Hazard Mater 2011;196:145-52.
46. Ma J, Xu R, Sun J, et al. Nanoparticle surface and nanocore properties determine the effect on radiosensitivity of cancer cells upon ionizing radiation treatment. J Nanosci Nanotechnol 2013;13:1472-5.
47. Coulter JA, Hyland WB, Nicol J, et al. Radiosensitising nanoparticles as novel cancer therapeutics - pipe dream or realistic prospect? Clin Oncol (R Coll Radiol) 2013;25:593-603.
48. Zheng Q, Yang H, Wei J, et al. The role and mechanisms of nanoparticles to enhance radiosensitivity in hepatocellular cell. Biomed Pharmacother 2013. [Epub ahead of print].
49. Boca SC, Potara M, Gabudean AM, et al. Chitosan-coated triangular silver nanoparticles as a novel class of biocompatible, highly effective photothermal transducers for in vitro cancer cell therapy. Cancer Lett 2011;311:131-40.
50. Xu R, Ma J, Sun X, et al. Ag nanoparticles sensitize IR-induced killing of cancer cells. Cell Res 2009;19:1031-4.
51. Brezesinski T, Smarsly B, Iimura K, et al. Self-assembly and crystallization behavior of mesoporous, crystalline HfO2 thin films: a model system for the generation of mesostructured transition-metal oxides. Small 2005;1:889-98.
52. Mendoza JG, Frutis MA, Flores GA, et al. Synthesis and characterization of hafnium oxide films for thermo and photoluminescence applications. Appl Radiat Isot 2010;68:696-9.
53. Maggiorella L, Barouch G, Devaux C, et al. Nanoscale radiotherapy with hafnium oxide nanoparticles. Future Oncol 2012;8:1167-81.
54. Juzenas P, Chen W, Sun YP, et al. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv Drug Deliv Rev 2008;60:1600-14.
55. Wang YH, Chen Z, Zhou XQ. Synthesis and photoluminescence of ZnS quantum dots. J Nanosci Nanotechnol 2008;8:1312-5.
56. Bakalova R, Ohba H, Zhelev Z, et al. Quantum dots as photosensitizers? Nat Biotechnol 2004;22:1360-1.
57. Shao L, Gao Y, Yan F. Semiconductor quantum dots for biomedicial applications. Sensors (Basel) 2011;11:11736-51.
58. Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 2008;60:1627-37.
59. Wadajkar AS, Menon JU, Kadapure T, et al. Design and Application of Magnetic-based Theranostic Nanoparticle Systems. Recent Pat Biomed Eng 2013;6:47-57.
60. Mikhaylov G, Vasiljeva O. Promising approaches in using magnetic nanoparticles in oncology. Biol Chem 2011;392:955-60.
61. Huang G, Chen H, Dong Y, et al. Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics 2013;3:116-26.
62. Klein S, Sommer A, Distel LV, et al. Superparamagnetic iron oxide nanoparticles as radiosensitizer via enhanced reactive oxygen species formation. Biochem Biophys Res Commun 2012;425:393-7.
63. Huang C, Neoh KG, Xu L, et al. Polymeric nanoparticles with encapsulated superparamagnetic iron oxide and conjugated cisplatin for potential bladder cancer therapy. Biomacromolecules 2012;13:2513-20.
64. Kettering M, Zorn H, Bremer-Streck S, et al. Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications. Phys Med Biol 2009;54:5109-21.
65. Raybaud-Diogène H, Fortin A, Morency R, et al. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study. J Clin Oncol 1997;15:1030-8.
66. Shen LF, Chen J, Zeng S, et al. The superparamagnetic nanoparticles carrying the E1A gene enhance the radiosensitivity of human cervical carcinoma in nude mice. Mol Cancer Ther 2010;9:2123-30.
67. Zhao D, Sun X, Tong J, et al. A novel multifunctional nanocomposite C225-conjugated Fe3O4/Ag enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy. Acta Biochim Biophys Sin (Shanghai) 2012;44:678-84.
68. Mallick S, Sun IC, Kim K, et al. Silica coated gold nanorods for imaging and photo-thermal therapy of cancer cells. J Nanosci Nanotechnol 2013;13:3223-9.
69. Elbialy N, Mohamed N, Monem AS. Preparation and characterization of SiO2-Au nanoshells: in vivo study of its photo-heat conversion. J Biomed Nanotechnol 2013;9:158-66.
70. 2 mesoporous nanoparticles for bimodal imaging and photothermal therapy. Chem Asian J 2013;8:385-91.
71. Wang Y, Chen L, Liu P. Biocompatible triplex Ag@SiO2@mTiO2 core-shell nanoparticles for simultaneous fluorescence-SERS bimodal imaging and drug delivery. Chemistry 2012;18:5935-43.
72. Zhao Z, Han Y, Lin C, et al. Multifunctional core-shell upconverting nanoparticles for imaging and photodynamic therapy of liver cancer cells. Chem Asian J 2012;7:830-7.
73. Zhang Z, Wang L, Wang J, et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater 2012;24:1418-23.
74. Klein S, Dell'Arciprete ML, Wegmann M, et al. Oxidized silicon nanoparticles for radiosensitization of cancer and tissue cells. Biochem Biophys Res Commun 2013;434:217-22.
75. Zhang Q, Yang W, Man N, et al. Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal. Autophagy 2009;5:1107-17.
76. Sayes CM, Gobin AM, Ausman KD, et al. Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterials 2005;26:7587-95.
77. Veeraraghavan J, Natarajan M, Lagisetty P, et al. Impact of curcumin, raspberry extract, and neem leaf extract on rel protein-regulated cell death/radiosensitization in pancreatic cancer cells. Pancreas 2011;40:1107-19.
78. Tishler RB, Geard CR, Hall EJ, et al. Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 1992;52:3495-7.
79. Jin C, Bai L, Wu H, et al. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro. Biomaterials 2007;28:3724-30.
80. Werner ME, Cummings ND, Sethi M, et al. Preclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2013;86:463-8.
81. Xu WH, Han M, Dong Q, et al. Doxorubicin-mediated radiosensitivity in multicellular spheroids from a lung cancer cell line is enhanced by composite micelle encapsulation. Int J Nanomedicine 2012;7:2661-71.
82. Werner ME, Copp JA, Karve S, et al. Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy. ACS Nano 2011;5:8990-8.
83. Patt HM, Tyree EB, Straube RL, et al. Cysteine Protection against X Irradiation. Science 1949;110:213-4.
84. Bari WA. Cysteine protection against the morphologic effects of x-irradiation on mouse spleen. Pathol Microbiol (Basel) 1968;32:205-18.
85. Jagetia GC. Radioprotection and radiosensitization by curcumin. Adv Exp Med Biol 2007;595:301-20.
86. Kumar KS, Srinivasan V, Toles R, et al. Nutritional approaches to radioprotection: vitamin E. Mil Med 2002;167:57-9.
87. Murray D, Altschuler EM, Hunter N, et al. Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage. Radiat Res 1989;120:339-51.
88. Capizzi RL, Oster W. Chemoprotective and radioprotective effects of amifostine: an update of clinical trials. Int J Hematol 2000;72:425-35.
89. Pamujula S, Kishore V, Rider B, et al. Radioprotection in mice following oral delivery of amifostine nanoparticles. Int J Radiat Biol 2005;81:251-7.
90. Theriot CA, Casey RC, Moore VC, et al. Dendro[C(60)]fullerene DF-1 provides radioprotection to radiosensitive mammalian cells. Radiat Environ Biophys 2010;49:437-45.
91. Trajković S, Dobrić S, Jaćević V, et al. Tissue-protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats. Colloids Surf B Biointerfaces 2007;58:39-43.
92. Hwang M, Yong C, Moretti L, et al. Zebrafish as a model system to screen radiation modifiers. Curr Genomics 2007;8:360-9.
93. Maurici D, Monti P, Campomenosi P, et al. Amifostine (WR2721) restores transcriptional activity of specific p53 mutant proteins in a yeast functional assay. Oncogene 2001;20:3533-40.
94. Suresh Reddy J, Venkateswarlu V, et al. Radioprotective effect of transferrin targeted citicoline liposomes. J Drug Target 2006;14:13-9.
95. Tarnuzzer RW, Colon J, Patil S, et al. Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett 2005;5:2573-7.
96. Vitolo JM, Cotrim AP, Sowers AL, et al. The stable nitroxide tempol facilitates salivary gland protection during head and neck irradiation in a mouse model. Clin Cancer Res 2004;10:1807-12.
97. Bütof R, Dubrovska A, Baumann M. Clinical perspectives of cancer stem cell research in radiation oncology. Radiother Oncol 2013. [Epub ahead of print].
98. Peitzsch C, Kurth I, Kunz-Schughart L, et al. Discovery of the cancer stem cell related determinants of radioresistance. Radiother Oncol 2013. [Epub ahead of print].
99. Zaffaroni N, Pennati M, Daidone MG. Survivin as a target for new anticancer interventions. J Cell Mol Med 2005;9:360-72.
100. Grdina DJ, Murley JS, Miller RC, et al. A survivin-associated adaptive response in radiation therapy. Cancer Res 2013;73:4418-28.
101. Yamada T, Horinaka M, Shinnoh M, et al. A novel HDAC inhibitor OBP-801 and a PI3K inhibitor LY294002 synergistically induce apoptosis via the suppression of survivin and XIAP in renal cell carcinoma. Int J Oncol 2013;43:1080-6.
102. Ling X, Cao S, Cheng Q, et al. A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activity. PLoS One 2012;7:e45571.
103. Pennati M, Millo E, Gandellini P, et al. RNA interference-mediated validation of survivin and Apollon/BRUCE as new therapeutic targets for cancer therapy. Curr Top Med Chem 2012;12:69-78.
104. Zhang M, Mukherjee N, Bermudez RS, et al. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo. Prostate 2005;64:293-302.
105. Gaca S, Reichert S, Rödel C, et al. Survivin-miRNA-loaded nanoparticles as auxiliary tools for radiation therapy: preparation, characterisation, drug release, cytotoxicity and therapeutic effect on colorectal cancer cells. J Microencapsul 2012;29:685-94.
106. Jakus J, Yeudall WA. Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells. Oncogene 1996;12:2369-76.
107. Schmidt-Ullrich RK, Contessa JN, Lammering G, et al. ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene 2003;22:5855-65.
108. Rubin Grandis J, Melhem MF, Gooding WE, et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998;90:824-32.
109. Patel JD. Epidermal growth factor receptor pathway targeted therapy in patients with aerodigestive malignancies. Curr Opin Oncol 2006;18:609-14.
110. Ping Y, Jian Z, Yi Z, et al. Inhibition of the EGFR with nanoparticles encapsulating antisense oligonucleotides of the EGFR enhances radiosensitivity in SCCVII cells. Med Oncol 2010;27:715-21.
111. Qiao Q, Jiang Y, Li G. Inhibition of the PI3K/AKT-NF-κB pathway with curcumin enhanced radiation-induced apoptosis in human Burkitt's lymphoma. J Pharmacol Sci 2013;121:247-56.
112. Elamin MH, Shinwari Z, Hendrayani SF, et al. Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells. Mol Carcinog 2010;49:302-14.